Concepedia

Jason G. Harb

JG

20

Publications

1.8K

Citations

16

H-Index

2008

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AbbVie (United States)

Dana-Farber Cancer Institute

The Ohio State University

Cancer Genetics (United States)

Jason G. Harb is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2008–2022

20

Publications

20

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani et al. · Cell · 2010 · 561 citations · Full text

, , +9

Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice

Stefan Costinean, Sukhinder K. Sandhu, Irene M. Pedersen et al. · Blood · 2009 · 287 citations · Full text

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

Paolo Neviani, Jason G. Harb, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2013 · 215 citations · Full text

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 145 citations · Full text

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies

Joshua J. Oaks, Ramasamy Santhanam, Christopher J. Walker et al. · Blood · 2013 · 108 citations · Full text

Rows per page

1–5 of 20